Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Hydrochloride Nasal Spray for Preoperative Sedation in Adults
NCT04383418Phase 3Completed
- Sponsor
- Hengrui
- Start
- May 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in preoperative sedation (3 arms), sponsored by Hengrui. Primary endpoint: Proportion of subjects who attained a Ramsay Sedation Score ≥3 at least once within 45 minutes. Started May 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
preoperative sedation
Beyond the preview
Go deeper on NCT04383418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04383418.